Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Learn More
Privileged Access to GI Immunology and Convergent Pathways
Changing the Paradigm for Biologics
Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares | Learn More
No events scheduled at this time.